Are you Dr. Yeilding?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
129 Edgewood Rd
Ardmore, PA 19003Phone+1 610-649-6847
Summary
- Dr. Newman Yeilding III, MD is an internist in Ardmore, Pennsylvania.
Publications & Presentations
PubMed
- 20 citationsDevelopment of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives - an update: Ustekinumab development as psoriasis treatmentNewman Yeilding, Philippe Szapary, Carrie Brodmerkel, Jacqueline Benson, Michael Plotnick
Annals of the New York Academy of Sciences. 2012-08-01 - 5 citationsDevelopment of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives.Newman Yeilding, Philippe Szapary, Carrie Brodmerkel, Jacqueline Benson, Michael Plotnick
Annals of the New York Academy of Sciences. 2011-03-01 - 184 citationsTumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapyMichael S. Gee, William N. Procopio, Sosina Makonnen, Michael Feldman, Newman M. Yeilding
The American Journal of Pathology. 2003-01-01
Press Mentions
‘Patient-Controlled’ Injector Approved for TremfyaMarch 8th, 2019
Janssen Gets FDA Approval for Tremfya One-Press Patient-Controlled InjectorFebruary 28th, 2019
Janssen Submits Application Seeking FDA Approval of Stelara® (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque PsoriasisDecember 20th, 2018- Join now to see all
